Spectral-domain optical coherence tomography in hydroxychloroquine retinopathy

Ophthalmology. 2015 Mar;122(3):651-2. doi: 10.1016/j.ophtha.2014.10.015. Epub 2014 Dec 17.

Authors

Janine L Johnston¹, Patty Darvill², Glen T D Thomson³

Affiliations

¹ Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Ophthalmology, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: novl@shaw.ca.
² Misericordia Health Center, Winnipeg, Manitoba, Canada.
³ Department of Family Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

PMID: 25530224
DOI: 10.1016/j.ophtha.2014.10.015

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Antirheumatic Agents / adverse effects*
Humans
Hydroxychloroquine / adverse effects*
Middle Aged
Retinal Diseases / chemically induced
Retinal Diseases / diagnosis*
Rheumatic Diseases / drug therapy
Sensitivity and Specificity
Tomography, Optical Coherence / methods*
Young Adult

Substances

Antirheumatic Agents
Hydroxychloroquine